Investigational Drug Information for Ifetroban
✉ Email this page to a colleague
What is the drug development status for Ifetroban?
Ifetroban is an investigational drug.
There have been 10 clinical trials for Ifetroban.
The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2014.
The most common disease conditions in clinical trials are Respiratory Tract Diseases, Respiration Disorders, and Asthma, Aspirin-Induced. The leading clinical trial sponsors are Cumberland Pharmaceuticals, Brigham and Women's Hospital, and Vanderbilt University Medical Center.
Summary for Ifetroban
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 2,231 |
| WIPO Patent Applications | 841 |
| Japanese Patent Applications | 332 |
| Clinical Trial Progress | Phase 2 (2014-08-01) |
| Vendors | 18 |
Recent Clinical Trials for Ifetroban
| Title | Sponsor | Phase |
|---|---|---|
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) or Non-IPF Progressive Pulmonary Fibrosis | Cumberland Pharmaceuticals | Phase 2 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Vanderbilt University Medical Center | Phase 2 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy | Cumberland Pharmaceuticals | Phase 2 |
Clinical Trial Summary for Ifetroban
Top disease conditions for Ifetroban
Top clinical trial sponsors for Ifetroban
US Patents for Ifetroban
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
